ProNova medPhoton Next Generation Beam Delivery Advanced Imaging Proton Therapy

October 6, 2014 — ProNova Solutions and medPhoton announced that they have agreed to form an exclusive partnership that will merge leading edge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market.

ProNova will integrate the medPhoton ImagingRing system into the SC360 proton therapy solution. The resulting system will include Fast Scanning IMPT technology with integrated 3-D imaging. This unique solution merges leading edge pencil beam delivery, innovative dual-energy 3-D imaging capability and precision positioning to aid physicians and therapists in minimizing collateral damage to healthy tissue and maximizing dose to the tumor. The ProNova compact superconducting gantry design allows for 360 degrees of patient treatment angle and improved workflow, resulting in faster treatment times and higher productivity.

medPhoton´s newly developed ImagingRing system is a slim, couch based, in-room CBCT device, capable of large field of view, low dose, single source dual energy 3-D volumetric and 2-D planar image acquisitions. It supports smooth workflows and highest precision in inter- and intrafractional image guided radiotherapy.

“medPhoton is glad that our hard research and development work over the last years will now have a real impact on the field. After having installed our first unit at the carbon beam facility MedAustron, we will now integrate our slim imaging ring system with ProNova’s cutting edgesmall footprint proton therapy equipment. In combination of both systems, precise beam adaptation and tracking of moving targets will be possible in the near future. A series of joint installations, research and clinical has been ordered,” says Heinz Deutschmann, chief executive officer and founder of medPhoton.

“ProNova is proud to partner with an innovative company like medPhoton,” said Joe Matteo, division president of ProNova Solutions, R&D and manufacturing. “Together we feel that this unique solution will enable clinicians to develop advanced proton therapy protocols for Adaptive Therapy.”

For more information: www.medphoton.at, pronovasolutions.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now